CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 82 filers reported holding CYTOMX THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 1.90 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $64,619 | -72.9% | 50,092 | -63.8% | 0.00% | -100.0% |
| Q2 2023 | $238,129 | -66.3% | 138,447 | -70.4% | 0.00% | -50.0% |
| Q1 2023 | $706,100 | -40.4% | 467,616 | -36.9% | 0.00% | -50.0% |
| Q4 2022 | $1,185,158 | +128.4% | 740,724 | +106.9% | 0.00% | +100.0% |
| Q3 2022 | $519,000 | -4.8% | 357,961 | +20.2% | 0.00% | 0.0% |
| Q2 2022 | $545,000 | -58.5% | 297,884 | -39.4% | 0.00% | -50.0% |
| Q1 2022 | $1,313,000 | +63.9% | 491,776 | +165.9% | 0.00% | +100.0% |
| Q4 2021 | $801,000 | +54.6% | 184,965 | +81.6% | 0.00% | +100.0% |
| Q3 2021 | $518,000 | -3.0% | 101,854 | +20.8% | 0.00% | 0.0% |
| Q2 2021 | $534,000 | -85.7% | 84,345 | -82.6% | 0.00% | -90.0% |
| Q1 2021 | $3,741,000 | +10.9% | 483,945 | -6.0% | 0.01% | 0.0% |
| Q4 2020 | $3,373,000 | +19.5% | 514,903 | +21.3% | 0.01% | 0.0% |
| Q3 2020 | $2,823,000 | +40.5% | 424,484 | +76.0% | 0.01% | 0.0% |
| Q2 2020 | $2,009,000 | +46.4% | 241,127 | +34.8% | 0.01% | -9.1% |
| Q1 2020 | $1,372,000 | -46.9% | 178,935 | -42.4% | 0.01% | +37.5% |
| Q4 2019 | $2,582,000 | +358.6% | 310,712 | +307.1% | 0.01% | +300.0% |
| Q3 2019 | $563,000 | -62.7% | 76,331 | -43.2% | 0.00% | -60.0% |
| Q2 2019 | $1,509,000 | +48.5% | 134,457 | +42.2% | 0.01% | +66.7% |
| Q1 2019 | $1,016,000 | -63.9% | 94,535 | -49.3% | 0.00% | -72.7% |
| Q4 2018 | $2,813,000 | -29.2% | 186,322 | -13.2% | 0.01% | 0.0% |
| Q3 2018 | $3,971,000 | -39.4% | 214,647 | -25.2% | 0.01% | -45.0% |
| Q2 2018 | $6,556,000 | +14.2% | 286,801 | +42.1% | 0.02% | +5.3% |
| Q1 2018 | $5,743,000 | +77.4% | 201,876 | +31.7% | 0.02% | +72.7% |
| Q4 2017 | $3,237,000 | +30.2% | 153,340 | +12.0% | 0.01% | +22.2% |
| Q3 2017 | $2,487,000 | +945.0% | 136,861 | +894.5% | 0.01% | +800.0% |
| Q1 2017 | $238,000 | – | 13,762 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 5,576,471 | $36,526,000 | 1.44% |
| Altium Capital Management LP | 273,703 | $1,793,000 | 0.67% |
| Jackson Creek Investment Advisors LLC | 80,367 | $526,000 | 0.21% |
| HARBOURVEST PARTNERS LLC | 79,193 | $519,000 | 0.20% |
| XTX MARKETS LLC | 14,169 | $93,000 | 0.19% |
| Perceptive Advisors | 2,577,043 | $16,880,000 | 0.18% |
| RTW INVESTMENTS, LP | 1,527,352 | $10,004,000 | 0.17% |
| Exane Asset Management | 30,568 | $200,220,000 | 0.14% |
| Virtus ETF Advisers LLC | 37,343 | $245,000 | 0.10% |
| Congress Park Capital LLC | 25,807 | $169,000 | 0.10% |